论文部分内容阅读
AIM To investigate the risk of end-stage renal disease(ESRD)in hepatitis B virus(HBV)-infected patients with chronic kidney disease(CKD)with and without nucleos(t)ide analogue(NA)therapy.METHODS This nationwide cohort study included 103444 Taiwanese CKD a